Innovation in an uncertain world

In the best of times, biotech innovation is full of uncertainty. But today's political, regulatory, and social upheaval have added more complexity than usual. How are cutting-edge biotech companies trying to compete in a global marketplace dealing with drug-price anger, science skepticism, and policies to close borders and protect jobs

Moderator: Alex Lash – Xconomy

• Annie De Groot – EpiVax
• Ji Li – BeiGene
• Kevin Sin – Genentech Partnering